X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (11) 11
adult (9) 9
female (9) 9
hematology (9) 9
middle aged (8) 8
male (7) 7
survival (7) 7
aged (6) 6
medical colleges (6) 6
oncology (6) 6
multiple myeloma (5) 5
treatment outcome (5) 5
acute myeloid leukemia (4) 4
analysis (4) 4
cancer (4) 4
care and treatment (4) 4
chemotherapy (4) 4
medicine & public health (4) 4
prognosis (4) 4
survival analysis (4) 4
acute myelogenous leukemia (3) 3
adolescent (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
autologous stem cell transplantation (3) 3
bone-marrow-transplantation (3) 3
hematopoietic stem cell transplantation (3) 3
lymphomas (3) 3
remission induction (3) 3
retrospective studies (3) 3
t cells (3) 3
transplantation (3) 3
versus-host-disease (3) 3
vidarabine - analogs & derivatives (3) 3
anthracyclines (2) 2
antineoplastic agents - administration & dosage (2) 2
antithymocyte globulin (2) 2
cell biology (2) 2
cell proliferation (2) 2
cohort studies (2) 2
combination (2) 2
combined modality therapy (2) 2
continuous infusion (2) 2
disease-free survival (2) 2
expression (2) 2
fludarabine (2) 2
hematologic malignancies (2) 2
hematopoietic stem cells (2) 2
immunology (2) 2
intermediate-dose cytarabine (2) 2
lenalidomide (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
lymphoma, extranodal nk-t-cell - mortality (2) 2
lymphoma, extranodal nk-t-cell - therapy (2) 2
methotrexate - therapeutic use (2) 2
mortality (2) 2
multiple myeloma - therapy (2) 2
nasal-type (2) 2
nuclear radiation (2) 2
open-label (2) 2
original paper (2) 2
pharmacology & pharmacy (2) 2
pharmacology/toxicology (2) 2
prognostic-factors (2) 2
prospective studies (2) 2
receptors (2) 2
recurrence (2) 2
research & development--r&d (2) 2
stem cells (2) 2
studies (2) 2
therapy (2) 2
vidarabine - therapeutic use (2) 2
young adult (2) 2
1st complete remission (1) 1
1st-line treatment (1) 1
60 applied life sciences (1) 1
a549 cells (1) 1
academic medical centers (1) 1
acute disease (1) 1
acute graft (1) 1
acute-leukemia (1) 1
adenocarcinoma (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - metabolism (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - physiopathology (1) 1
adenocarcinoma - secondary (1) 1
adipocyte differentiation (1) 1
adipocytes (1) 1
adipocytes - cytology (1) 1
adipocytes - drug effects (1) 1
adipocytes - metabolism (1) 1
adipogenesis (1) 1
age factors (1) 1
aged patients (1) 1
alizarin (1) 1
alizarin staining (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 389 - 400
Journal Article
Tumor Biology, ISSN 1010-4283, 5/2019, Volume 41, Issue 5, pp. 101042831984861 - 50
Aurora kinases play critical roles in regulating several processes pivotal for mitosis. Radotinib, which is approved in South Korea as a second-line treatment... 
radotinib | antileukemic activity | Aurora kinase | cell cycle arrest | Acute myeloid leukemia | Myeloid leukemia | Mitosis
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0166589
LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus... 
VIRUS ENTRY MEDIATOR | MULTIDISCIPLINARY SCIENCES | CO-STIMULATION | METHODOLOGICAL APPROACH | ALPHA | AMYOTROPHIC-LATERAL-SCLEROSIS | LYMPHOTOXIN/LIGHT | SOLUBLE DECOY RECEPTOR-3 | STROMAL CELLS | VERSUS-HOST-DISEASE | TRANSPLANTATION | Osteocytes - drug effects | Cyclin-Dependent Kinases - metabolism | Humans | Cyclins - genetics | Adipocytes - drug effects | Lymphotoxin beta Receptor - metabolism | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Mesenchymal Stromal Cells - cytology | Cyclins - metabolism | Microarray Analysis | STAT3 Transcription Factor - genetics | Cell Survival - drug effects | Cyclin-Dependent Kinase 2 - metabolism | Mesenchymal Stromal Cells - drug effects | Signal Transduction | Osteocytes - cytology | Cyclin-Dependent Kinase 2 - genetics | Mesenchymal Stromal Cells - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 14 - metabolism | Lymphotoxin beta Receptor - genetics | CDC2 Protein Kinase | Chondrocytes - cytology | Tumor Necrosis Factor Ligand Superfamily Member 14 - pharmacology | Adipocytes - cytology | Smad3 Protein - metabolism | Platelet-Derived Growth Factor - genetics | Tumor Necrosis Factor Ligand Superfamily Member 14 - genetics | Chondrocytes - drug effects | Smad3 Protein - genetics | Bone Marrow Cells - drug effects | Cyclin-Dependent Kinases - genetics | Chondrocytes - metabolism | STAT3 Transcription Factor - metabolism | Recombinant Proteins - metabolism | Osteocytes - metabolism | Bone Marrow Cells - cytology | Gene Expression Regulation | Recombinant Proteins - genetics | Recombinant Proteins - pharmacology | Platelet-Derived Growth Factor - metabolism | Transforming Growth Factor beta - genetics | Cell Cycle | Cell Differentiation - drug effects | Adipocytes - metabolism | Cell Proliferation - drug effects | Primary Cell Culture | Transforming Growth Factor beta - metabolism | Bone Marrow Cells - metabolism | Cyclin-Dependent Kinase Inhibitor p27 - genetics | Platelet-derived growth factor | Dendritic cells | Tumor necrosis factor | Stem cells | Transplantation | B cells | T cells | Transforming growth factors | Enzyme-linked immunosorbent assay | Herpes simplex | Immunoblotting | Adipocytes | Alizarin | Proteins | Signal transduction | Receptors | Cell growth | Light | Bone marrow | CD25 antigen | Biocompatibility | Chondrogenesis | Glycoprotein D | Glycoprotein | Survival | Hospitals | Stromal cells | Herpes viruses | Lymphomas | Viability | Cell proliferation | Biomedical research | Mesenchyme | Leukemia | Multiple myeloma | Staining | Homology | Viruses | Oncology | Lymphocytes T | Smad3 protein | Bone diseases | Cell surface | Cyclin B1 | Biomedical materials | Lymphocytes | Cell cycle | Tumor necrosis factor-TNF | Adipogenesis | Cell survival | Hematology | Research & development--R&D | Stat3 protein | Cyclins | Cyclin-dependent kinase 2 | Medicine | Cell number | Bone | Osteogenesis | Research & development | R&D
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 10/2016, Volume 479, Issue 2, pp. 152 - 158
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 09/2017, Volume 23, Issue 9, pp. 1555 - 1566
To investigate the role of antithymocyte globulin (ATG)-containing reduced-intensity conditioning (RIC) in hematopoietic cell transplantation (HCT) from... 
Fludarabine | HLA-haploidentical family donor | Allogeneic hematopoietic cell transplantation | HLA-matched sibling donor | Busulfan | Acute myeloid leukemia | Antithymocyte globulin | HLA-matched unrelated donor | ANTI-THYMOCYTE-GLOBULIN | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | HLA-A | IMMUNOLOGY | VERSUS-HOST-DISEASE | 1ST COMPLETE REMISSION | TRANSPLANTATION | ACUTE GRAFT | POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | CUMULATIVE INCIDENCE | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | Myeloablative Agonists - therapeutic use | Recurrence | Prospective Studies | Multiple Myeloma - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Multiple Myeloma - immunology | Methotrexate - therapeutic use | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Multiple Myeloma - therapy | Graft vs Host Disease - mortality | Antilymphocyte Serum - therapeutic use | Adult | Female | Unrelated Donors | Transplantation Conditioning - methods | Siblings | Acute Disease | Busulfan - therapeutic use | Histocompatibility Testing | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Graft vs Host Disease - pathology | Cyclosporine - therapeutic use | Multiple Myeloma - pathology | Adolescent | Survival Analysis | Graft vs Host Disease - prevention & control | Aged | Transplantation, Haploidentical | Chronic Disease | Transplantation | Hematopoietic stem cells | Medical colleges | Mortality
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2016, Volume 96, Issue 2, pp. 188 - 197
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2013, Volume 72, Issue 1, pp. 201 - 207
Journal Article
Acta Haematologica, ISSN 0001-5792, 06/2014, Volume 132, Issue 1, pp. 87 - 96
Journal Article
Journal Article